Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder characterized by complement-mediated hemolysis, thrombosis, and bone marrow failure. Iptacopan, an oral factor B inhibitor, has demonstrated efficacy in managing PNH but has not been studied in patients with severe renal insufficiency. We...
Saved in:
| Main Authors: | Ting Wu, Xiaoqin Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1583394/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment
by: Cameron Perry, et al.
Published: (2025-06-01) -
Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: the EPIC program
by: Hayeong Rho, et al.
Published: (2025-07-01) -
Crovalimab: A Novel Approach in the Management of Paroxysmal Nocturnal Hemoglobinuria
by: Laiba Jalal, et al.
Published: (2025-07-01) -
CHRONIC HEPATITIS OR «DISGUISE» PAROXYSMAL NOCTURAL HEMOGLOBINURIA?
by: D. A. Dolgopolova, et al.
Published: (2015-08-01) -
Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)
by: A. Amendola, et al.
Published: (2021-04-01)